The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis (original) (raw)

• Weinert, T. DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell 94, 555–558 (1998).
  Article CAS Google Scholar
• Hartwell, L. H. & Kastan, M. B. Cell cycle control and cancer. Science 266, 1821–1828 (1994).
  Article ADS CAS Google Scholar
• Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664–1672 (1996).
  Article ADS CAS Google Scholar
• Painter, R. B. & Young, B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl Acad. Sci. USA 77, 7315–7317 (1980).
  Article ADS CAS Google Scholar
• Rotman, G. & Shiloh, Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 18, 6135–6144 (1999).
  Article CAS Google Scholar
• Stewart, G. S. et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99, 577–587 (1999).
  Article CAS Google Scholar
• Galaktionov, K. & Beach, D. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell 67, 1181–1194 (1991).
  Article CAS Google Scholar
• Hoffmann, I., Draetta, G. & Karsenti, E. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13, 4302–4310 (1994).
  Article CAS Google Scholar
• Jinno, S. et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13, 1549–1556 (1994).
  Article CAS Google Scholar
• Mailand, N. et al. Rapid destruction of Cdc25A in response to DNA damage. Science 288, 1425–1429 (2000).
  Article ADS CAS Google Scholar
• Molinari, M. et al. Human Cdc25A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Reps 1, 71–79 (2000).
  Article CAS Google Scholar
• Matsuoka, S., Huang, M. & Elledge, S. J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893–1897 (1998).
  Article ADS CAS Google Scholar
• Bell, D. W. et al. Heterozygous germ line hCHK2 mutations in Li–Fraumeni syndrome. Science 286, 2528–2531 (1999).
  Article CAS Google Scholar
• Gu, Y., Rosenblatt J. & Morgan, D. O. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11, 3995–4005 (1992).
  Article CAS Google Scholar
• Boddy, M. N., Furnari, B., Mondesert, O. & Russell, P. Replication checkpoint enforced by kinases Cds1 and Chk1. Science 280, 909–912 (1998).
  Article ADS CAS Google Scholar
• Furnari, B., Rhind, N. & Russell, P. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277, 1495–1497 (1997).
  Article CAS Google Scholar
• Peng, C. Y. et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501–1505 (1997).
  Article CAS Google Scholar
• Sanchez, Y. et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497–1501 (1997).
  Article CAS Google Scholar
• Zeng, Y. et al. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature 395, 507–510 (1998).
  Article ADS CAS Google Scholar
• Chehab, N. H., Malikzay, A., Appel, M. & Halazonetis, T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev. 14, 278–288 (2000).
  CAS PubMed PubMed Central Google Scholar
• Sun, Z., Hsiao, J., Fay, D. S. & Stern, D. F. Rad 53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint. Science 281, 272–274 (1998).
  Article ADS CAS Google Scholar
• Durocher, D., Henckel, J., Fersht, A. R. & Jackson, S. P. The FHA domain is a modular phosphopeptide recognition motif. Mol. Cell 4, 387–394 (1999).
  Article CAS Google Scholar
• Hirao, A. et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824–1827 (2000).
  Article ADS CAS Google Scholar
• Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W. & Vogelstein, B. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616–620 (1999).
  Article ADS CAS Google Scholar
• Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973–2983 (1998).
  Article CAS Google Scholar
• Lim, D. S. et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404, 613–617 (2000).
  Article ADS CAS Google Scholar
• Xie, G. et al. Requirements for p53 and ATM gene product in the regulation of G1/S and S phase checkpoints. Oncogene 16, 721–736 (1998).
  Article CAS Google Scholar
• Galaktionov, K. et al. CDC25 phosphatases as potential human oncogenes. Science 269, 1575–1577 (1995).
  Article ADS CAS Google Scholar
• Lee, J. S., Collins, K. M., Brown, A. L., Lee, C. H. & Chung, J. H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201–204 (2000).
  Article ADS CAS Google Scholar
• Santoni-Rugiu, E., Falck, J., Mailand, N., Bartek, J & Lukas, J. Involvement of Myc activity in a G1/S-promoting mechanism parallel to the pRb/E2F pathway. Mol. Cell. Biol. 20, 3497–3509 (2000).
  Article CAS Google Scholar